Ropine Sulfate Injection Usp 0.6 Mg/ml (2017-07-17)

Atropine Sulfate Injection USP 0.6 mg/ml Recall Atropine Sulfate Injection USP 0.6 mg/ml is being recalled across Canada due to product safety concerns. This injectable medication is used in medical settings for various purposes including treating certain types of poisoning and managing heart conditions. The recall affects all batches distributed throughout Canada.

Reason
Product safety
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2017-10-04
Status
Closed
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/62f8cf99-7d09-45b8-a7d7-2bbc0293543d